Oridonin inhibits aberrant AKT activation in breast cancer
Publication information:
Sun B, Wang G, Liu H, Liu P, Twal W, Cheung H, Carroll S, Ethier S, Mevers E, Clardy J, Roberts T, Chen C, Li, Wang L, Yang M, Zhao J, Wang. Oridonin inhibits aberrant AKT activation in breast cancer.
Oncotarget. 2018;9(35):23878–23889.